Clinical Trial Update: Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating capecitabine and panitumumab with radiation therapy, with or without irinotecan, in patients undergoing surgery for localized rectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
• Panitumumab (panitumumab)

Snippet

Sponsor: Loma Linda Oncology Medical Group, Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN